SARS-CoV-2 Antigen Rapid Test
Providing an aid in early diagnosis of individuals who are suspected of COVID-19 by their healthcare provider and who are asymptomatic.
Providing an aid in early diagnosis of individuals who are suspected of COVID-19 by their healthcare provider and who are asymptomatic.
• Single-well, triple target assay covering high conserved regions within N, E and ORF 1ab gene for high specificity.
• Full-process controls with negative, positive and internal controls.
• Qualitative detection of nucleic acids from SARS-CoV-2
Contact us
|
Features |
Specifications |
|
Technology |
Real-Time reverse transcription polymerase chain reaction (rRT-PCR) |
|
Target Region |
N, E, ORF1ab |
|
Specimen Type |
Oropharyngeal swab, nasopharyngeal swab and deep cough sputum |
|
Internal Control |
Yes |
|
Minimum Sample Volume |
200 µl |
|
Test Duration |
90 minutes |
|
Limit of Detection |
500 copies/mL |
|
Precision of In-batch and batch(CV) |
＜5% |
|
Positive Percent Agreement |
97.46% (95%CI:92.75%-99.47%) |
|
Negative Percent Agreement |
98.26% (95%CI:94.99%-99.64%) |
|
Accuracy |
97.93% (95%CI:95.56%-99.24%) |
|
Storage Temperature |
-20±5 ℃ |
|
Package Size |
32 Tests/Kit |
|
Cat. No. |
Product |
Size |
|
P131-1591 |
SARS-CoV-2 RT-PCR Test Kit |
32 Tests/Kit |
